Percheron Therapeutics Ltd. (PERCF)
0.0024
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Percheron Therapeutics Cash from Operations (TTM) : -3.485M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.485M |
| December 31, 2025 | -6.031M |
| June 30, 2025 | -9.924M |
| December 31, 2024 | -9.080M |
| June 30, 2024 | -6.630M |
| December 31, 2023 | -6.941M |
| June 30, 2023 | -5.492M |
| December 31, 2022 | -4.738M |
| June 30, 2022 | -5.656M |
| December 31, 2021 | -5.700M |
| June 30, 2021 | -4.411M |
| December 31, 2020 | -2.984M |
| June 30, 2020 | -2.630M |
| December 31, 2019 | -2.061M |
| June 30, 2019 | -2.093M |
| December 31, 2018 | -2.056M |
| June 30, 2018 | -1.782M |
| December 31, 2017 | -1.972M |
| June 30, 2017 | -2.198M |
| December 31, 2016 | -1.386M |
| June 30, 2016 | -1.469M |
| December 31, 2015 | 0.4438M |
| June 30, 2015 | 0.9236M |
| December 31, 2014 | -2.728M |
| June 30, 2014 | -2.847M |
| Date | Value |
|---|---|
| December 31, 2013 | -1.836M |
| June 30, 2013 | -2.914M |
| December 31, 2012 | -2.908M |
| June 30, 2012 | -2.480M |
| December 31, 2011 | -2.546M |
| June 30, 2011 | -1.867M |
| December 31, 2010 | -1.509M |
| June 30, 2010 | -1.184M |
| December 31, 2009 | -1.745M |
| June 30, 2009 | -2.398M |
| December 31, 2008 | -2.387M |
| June 30, 2008 | -3.036M |
| December 31, 2007 | -2.931M |
| June 30, 2007 | -2.117M |
| December 31, 2006 | -2.379M |
| June 30, 2006 | -2.957M |
| December 31, 2005 | -3.093M |
| June 30, 2005 | -4.317M |
| December 31, 2004 | -3.648M |
| June 30, 2004 | -1.588M |
| December 31, 2003 | -2.725M |
| June 30, 2003 | -4.089M |
| December 31, 2002 | -3.670M |
| June 30, 2002 | -2.150M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Starpharma Holdings Ltd. | -2.255M |
| Neuren Pharmaceuticals Ltd. | 6.411M |
| Mayne Pharma Group Ltd. | 10.97M |
| Acrux Ltd. | 0.7159M |
| Zelira Therapeutics Ltd. | -3.113M |